{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:30:35Z","timestamp":1761395435136,"version":"3.40.5"},"reference-count":18,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"unspecified","delay-in-days":59,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2019]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>As part of the evaluation of the French plan for the elimination of measles and rubella, we conducted a seroprevalence survey in 2013, aimed at updating seroprevalence data for people 18\u201332 years old. A secondary objective was to estimate measles incidence in this population during the 2009\u20132011 outbreak, and thus estimate the exhaustiveness of measles mandatory reporting. We used a cross-sectional survey design, targeting blood donors 18\u201332 years old, living in France since 2009, who came to give blood in a blood collecting site. We included 4647 people in metropolitan France, 806 people in R\u00e9union Island and 496 in the French Caribbean. A further 3942 individuals were interviewed in the south-east region of metropolitan France to estimate the exhaustiveness of measles mandatory reporting. One of the main findings of this survey is that the proportion of people 18\u201332 years old susceptible to both measles and rubella infections remained high in France in 2013, 9.2% and 5.4%, respectively, in metropolitan France, even after the promotion campaigns about vaccination catch-up during and following the major measles epidemic in 2009\u20132011. Applying our results to French census data would suggest that around 1 million people aged 18\u201332 years old are currently susceptible to measles in France, despite this age group being one of the vaccination targets of the national measles elimination plan. Another important finding is that only an estimated 45% of the true number of cases in this age group was actually notified, despite notification being mandatory.<\/jats:p>","DOI":"10.1017\/s0950268819000050","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T05:31:55Z","timestamp":1551418315000},"source":"Crossref","is-referenced-by-count":14,"title":["Measles and rubella seroprevalence in a population of young adult blood donors, France 2013"],"prefix":"10.1017","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5344-7787","authenticated-orcid":false,"given":"D.","family":"Antona","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Morel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Jacquot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Fonteneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Vauloup-Fellous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gimeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Degeorges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gallian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"L\u00e9vy-Bruhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2019,3,1]]},"reference":[{"key":"S0950268819000050_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70282-2"},{"key":"S0950268819000050_ref16","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.07.046375"},{"key":"S0950268819000050_ref14","unstructured":"Sant\u00e9 publique France. Measles epidemiological bulletin. Available at http:\/\/invs.santepubliquefrance.fr\/Dossiers-thematiques\/Maladies-infectieuses\/Maladies-a-prevention-vaccinale\/Rougeole\/Points-d-actualites (Accessed 25 September 2018)."},{"key":"S0950268819000050_ref13","unstructured":"Haute autorit\u00e9 de sant\u00e9. Avis n\u00b02018.0001\/AC\/SEESP du 10 janvier 2018 du coll\u00e8ge de la Haute Autorit\u00e9 de sant\u00e9 concernant le projet de d\u00e9cret relatif \u00e0 la vaccination obligatoire, pris en application de l'article 49 de la loi n\u00b0 2017-1836 du 30 d\u00e9cembre 2017 de financement de la s\u00e9curit\u00e9 sociale pour 2018. Available at https:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2018-01\/avis_n2018_0001_du_10_janvier_2018_du_college_de_la_haute_autorite_de_sante_concernant_le_projet_de_de.pdf (Accessed 11 May 2018)."},{"key":"S0950268819000050_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4557-0090-5.00028-8"},{"key":"S0950268819000050_ref11","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.3.477"},{"key":"S0950268819000050_ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890410110"},{"key":"S0950268819000050_ref9","unstructured":"Ramsay M . A strategic framework for the elimination of measles in the European Region. Copenhagen: Expanded Programme on Immunization in the European Region of WHO, 1999 (EUR\/ICP\/CMDS 01 01 05). Available at http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0003\/119802\/E68405.pdf (Accessed 11 May 2018)."},{"key":"S0950268819000050_ref8","unstructured":"Haut Conseil de la sant\u00e9 publique. Avis relatif \u00e0 l'actualisation des recommandations vaccinales contre la rougeole pour les adultes, 11 f\u00e9vrier 2011. Available at http:\/\/www.hcsp.fr\/explore.cgi\/avisrapportsdomaine?clefr=198 (Accessed 11 May 2018)."},{"key":"S0950268819000050_ref5","doi-asserted-by":"publisher","DOI":"10.3201\/eid1903.121360"},{"volume-title":"European Vaccine Action Plan 2015\u20132020","year":"2015","key":"S0950268819000050_ref3"},{"key":"S0950268819000050_ref2","unstructured":"World Health Organization Regional Office for Europe. Regional Committee for Europe. Sixtieth session; 2010. Renewed commitment to elimination of measles and rubella and prevention of congenital rubella syndrome by 2015 and sustained support for polio-free status in the WHO European Region. Available at http:\/\/www.who.int\/immunization\/sage\/3_Resolution_EURO_RC60_eRes12.pdf (Accessed 11 May 2018)."},{"key":"S0950268819000050_ref1","unstructured":"World Health Organization Regional Office for Europe. Eliminating measles and rubella and prevention congenital rubella infection. WHO European Region strategic plan 2005\u20132010. Available at http:\/\/www.euro.who.int\/document\/E87772.pdf (Accessed 11 May 2018)."},{"key":"S0950268819000050_ref7","unstructured":"Lepoutre A (2013) Seroprevalence of vaccine preventable diseases and of five other infectious diseases in France. Results of two national surveys, 2008\u20132010. Bulletin Epid\u00e9miologique Hebdomadaire, 526\u2013534. Available at http:\/\/invs.santepubliquefrance.fr\/beh\/2013\/41-42\/2013_41-42_1.html (Accessed 11 May 2018)."},{"key":"S0950268819000050_ref6","unstructured":"Sant\u00e9 publique France. Measles and rubella vaccine coverage. Available at http:\/\/invs.santepubliquefrance.fr\/Dossiers-thematiques\/Maladies-infectieuses\/Maladies-a-prevention-vaccinale\/Couverture-vaccinale\/Donnees\/Rougeole-rubeole-oreillons (Accessed 11 May 2018)."},{"key":"S0950268819000050_ref4","unstructured":"Minist\u00e8re de la Sant\u00e9 et des Solidarit\u00e9s. Plan d\u2019\u00e9limination de la rougeole et de la rub\u00e9ole cong\u00e9nitale en France, 2005\u20132010. Available at http:\/\/www.sante.gouv.fr\/IMG\/pdf\/plan_elimination_rougeole.pdf (Accessed 11 May 2018)."},{"key":"S0950268819000050_ref18","unstructured":"Sant\u00e9 publique France. Measles-Mumps-Rubella vaccine coverage in France. Available at http:\/\/invs.santepubliquefrance.fr\/Dossiers-thematiques\/Maladies-infectieuses\/Maladies-a-prevention-vaccinale\/Couverture-vaccinale\/Donnees\/Rougeole-rubeole-oreillons. (Accessed 25 September 2018)."},{"key":"S0950268819000050_ref15","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix112"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268819000050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T17:48:36Z","timestamp":1559929716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268819000050\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":18,"alternative-id":["S0950268819000050"],"URL":"https:\/\/doi.org\/10.1017\/s0950268819000050","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"type":"print","value":"0950-2688"},{"type":"electronic","value":"1469-4409"}],"subject":[],"published":{"date-parts":[[2019]]},"article-number":"e109"}}